Phreesia Announces Fiscal Second Quarter 2020 Earnings Conference Call

NEW YORK, Aug. 19, 2019 /PRNewswire/ — Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Tuesday, September 10, 2019, at 8:30 a.m. Eastern Time to review the Company’s fiscal second quarter 2020 financial results. A press release announcing the fiscal second quarter financial results will be issued after the close of market trading on Monday, September 9, 2019.

To participate in the company’s live conference call and webcast, please dial (866) 211-4557 ((647) 689-6750 for international participants) using conference code number 9796424, or visit the “Events & Presentations” section of ir.phreesia.com.

ABOUT PHREESIA
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care.

Investors:
Balaji Gandhi
Phreesia, Inc.
investors@phreesia.com
(929) 506-4950

Media:
Maureen McKinney
Phreesia Inc.
mmckinney@phreesia.com
773-330-8908

View original content to download multimedia:http://www.prnewswire.com/news-releases/phreesia-announces-fiscal-second-quarter-2020-earnings-conference-call-300903485.html

SOURCE Phreesia, Inc.

Staff

Recent Posts

Nutriband Provides Clinical and Regulatory Path Overview for Lead Product – AVERSA(R) Fentanyl Transdermal Patch

NDA will be primarily based on a single Phase 1 human abuse potential clinical study…

48 mins ago

Life Chemicals Partners With Bioz to Provide Customers With Product Usage Information From Scientific Literature

PALO ALTO, CA / ACCESSWIRE / March 27, 2024 / Bioz, Inc., a scientific research-focused…

48 mins ago

Cantargia Reports Progress Towards Start of DOD-Sponsored Clinical Trial of Nadunolimab in Leukemia

LUND, SWEDEN / ACCESSWIRE / March 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq…

4 hours ago

RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting

Relief Therapeutics Calls Extraordinary General Meeting Anticipated Board of Directors OverhaulGENEVA, SWITZERLAND / ACCESSWIRE /…

4 hours ago

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Pivotal Trial for Improving Overall Function and Quality of LifeSALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, a pioneer…

13 hours ago

AARC Celebrates Introduction of the SOAR Act in the House of Representatives

Bill passage key to supplemental oxygen access and adequate reimbursementIRVING, TX / ACCESSWIRE / March…

16 hours ago